Stock Scorecard



Stock Summary for AVITA Medical Inc (RCEL) - $14.58 as of 9/28/2023 8:11:50 PM EST

Total Score

8 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for RCEL

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for RCEL

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for RCEL

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for RCEL

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for RCEL

AVITA Medical Receives Best Product Award at the American Association for the Surgery of Trauma 9/25/2023 12:00:00 PM
AVITA Medical to Present at the Cantor Global Healthcare Conference 9/21/2023 8:30:00 PM
AVITA Medical to Present at the Cantor Global Healthcare Conference - AVITA Medical ( NASDAQ:RCEL ) 9/21/2023 8:30:00 PM
AVITA Medical to Participate in Upcoming Investor Conferences 9/6/2023 10:45:00 PM
AVITA Medical to Participate in Upcoming Investor Conferences - AVITA Medical ( NASDAQ:RCEL ) 9/6/2023 10:45:00 PM
AVITA Medical to Host Investor Webinar Briefing - AVITA Medical ( NASDAQ:RCEL ) 8/14/2023 12:00:00 PM
Strength Seen in Avita Medical Inc. ( RCEL ) : Can Its 20.4% Jump Turn into More Strength? 7/14/2023 10:59:00 AM
Stratasys, MillerKnoll, Nikola And Other Big Stocks Moving Higher On Thursday - ACM Research ( NASDAQ:ACMR ) , Affirm Holdings ( NASDAQ:AFRM ) 7/13/2023 2:59:00 PM
AVITA Medical Submits FDA PMA Supplement for RECELL GO - AVITA Medical ( NASDAQ:RCEL ) 6/29/2023 10:21:00 PM
AVITA Medical Submits FDA PMA Supplement for RECELL GO 6/29/2023 10:21:00 PM

Financial Details for RCEL

Company Overview

Ticker RCEL
Company Name AVITA Medical Inc
Country USA
Description AVITA Medical Inc. is a commercial stage regenerative tissue company in the United States, Australia, and the United Kingdom. The company is headquartered in Valencia, California.
Sector Name LIFE SCIENCES
Industry Name SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Most Recent Quarter 6/30/2023
Next Earnings Date 11/8/2023

Stock Price History

Last Day Price 14.58
Last Day Price Updated 9/28/2023 8:11:50 PM EST
Last Day Volume 66,447
Average Daily Volume 97,015
52-Week High 21.70
52-Week Low 4.41
Last Price to 52 Week Low 230.61 %

Valuation Measures

Trailing PE N/A
Industry PE 82.78
Sector PE 47.89
5-Year Average PE -14.40
Free Cash Flow Ratio 3.93
Industry Free Cash Flow Ratio 69.10
Sector Free Cash Flow Ratio 31.90
Current Ratio Most Recent Quarter 5.61
Total Cash Per Share 3.71
Book Value Per Share Most Recent Quarter 0.54
Price to Book Ratio 2.10
Industry Price to Book Ratio 6.78
Sector Price to Book Ratio 21.80
Price to Sales Ratio Twelve Trailing Months 6.63
Industry Price to Sales Ratio Twelve Trailing Months 5.43
Sector Price to Sales Ratio Twelve Trailing Months 3.72

Share Statistics

Total Shares Outstanding 25,478,300
Market Capitalization 371,473,614
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00 %
5-Year Dividend Payments Count 0
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00 %
Annual Earnings Growth -0.31 %
Reported EPS 12 Trailing Months -1.22
Reported EPS Past Year -1.22
Reported EPS Prior Year -1.21
Net Income Twelve Trailing Months -30,545,000
Net Income Past Year -26,665,000
Net Income Prior Year -26,583,000
Quarterly Revenue Growth YOY 41.00 %
5-Year Revenue Growth 84.58 %

Balance Sheet

Total Cash Most Recent Quarter 94,609,000
Total Cash Past Year 94,609,000
Total Cash Prior Year 140,520,000
Net Cash Position Most Recent Quarter 94,609,000
Net Cash Position Past Year 94,609,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 68,647,000
Total Stockholder Equity Prior Year 84,740,000
Total Stockholder Equity Most Recent Quarter 68,647,000

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating None

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.61
MACD Signal -0.51
20-Day Bollinger Lower Band 10.78
20-Day Bollinger Middle Band 16.10
20-Day Bollinger Upper Band 21.41
Beta 1.18
RSI 29.86
50-Day SMA 12.10
200-Day SMA 18.49

System

Modified 9/28/2023 9:58:28 AM EST